Cargando…
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
Many aptamers have been evaluated for their ability as drug delivery vehicles to target ligands, and a variety of small interfering RNAs (siRNAs) have been tested for their anti-cancer properties. However, since these two types of molecules have similar physicochemical properties, it has so far been...
Autores principales: | Kim, Min Woo, Jeong, Hwa Yeon, Kang, Seong Jae, Jeong, In Ho, Choi, Moon Jung, You, Young Myoung, Im, Chan Su, Song, In Ho, Lee, Tae Sup, Lee, Jin Suk, Lee, Aeju, Park, Yong Serk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376474/ https://www.ncbi.nlm.nih.gov/pubmed/30809312 http://dx.doi.org/10.7150/thno.30228 |
Ejemplares similares
-
Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
por: Kim, Min Woo, et al.
Publicado: (2017) -
Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023) -
EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms
por: Choi, Moon Jung, et al.
Publicado: (2022) -
Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim, Jung Seok, et al.
Publicado: (2018) -
Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
por: Rhee, Jin-Kyu, et al.
Publicado: (2014)